| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90935 |
|
9,116 |
1,012 |
$179K |
| A4657 |
Syringe, with or without needle, each |
1,240 |
782 |
$83K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
3,132 |
587 |
$22K |
| J1756 |
Injection, iron sucrose, 1 mg |
667 |
205 |
$870.11 |
| 85046 |
|
180 |
158 |
$754.89 |
| 83970 |
|
303 |
262 |
$171.40 |
| 82728 |
|
314 |
268 |
$152.70 |
| J1270 |
Injection, doxercalciferol, 1 mcg |
3,864 |
485 |
$148.77 |
| 82306 |
|
157 |
135 |
$147.56 |
| 83550 |
|
334 |
280 |
$130.53 |
| 83540 |
|
332 |
280 |
$105.16 |
| 85041 |
|
592 |
502 |
$55.66 |
| 85048 |
|
591 |
501 |
$53.15 |
| 82108 |
|
33 |
29 |
$18.09 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
68 |
34 |
$0.00 |